as of 04-02-2026 3:59pm EST
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | NEWARK |
| Market Cap: | 63.5M | IPO Year: | 2017 |
| Target Price: | N/A | AVG Volume (30 days): | 68.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.32 | EPS Growth: | 28.28 |
| 52 Week Low/High: | $1.12 - $3.19 | Next Earning Date: | 03-16-2026 |
| Revenue: | $917,000 | Revenue Growth: | 43.96% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -3.81 | Index: | N/A |
| Free Cash Flow: | -18928000.0 | FCF Growth: | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
SEC 8-K filings with transcript text
Mar 16, 2026 · 100% conf.
1D
+2.58%
$1.34
Act: +0.76%
5D
+1.12%
$1.32
20D
-1.03%
$1.30
false 0001713863
0001713863
2026-03-16 2026-03-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 16, 2026
(Exact name of registrant as specified in its charter)
Delaware
1-38411
82-2296593
(State or other jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
520 Broad Street
Newark, New Jersey
07102
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: 212 658-1450
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b)-2 of the Exchange Act:
Title of each class
Trading Symbol
Name of each exchange on
which registered
Class B common stock, par value $0.01 per share
RFL
New York Stock Exchange
Item 2.02. Results of Operations and Financial Condition.
On March 16, 2026, Rafael Holdings, Inc. (the “Company”) distributed over a wire service and posted an earnings release to the investors page of its website (www.rafaelholdings.com) announcing its results of operations for the fiscal quarter ended January 31, 2026. A copy of the earnings release concerning the foregoing results is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
The Company is furnishing the information contained in this Report, including Exhibit 99.1, pursuant to Item 2.02 of Form 8-K promulgated by the Securities and Exchange Commission (the “SEC”). This information shall not be deemed to be “filed” with the SEC or incorporated by reference into any other filing with the SEC unless otherwise expressly stated in such filing. In addition, this Report and the press release contain statements intended as “forward-looking statements” that are subject to the cautionary statements about forward-looking statements set forth in the press release.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Document
99.1
Press Release, dated March 16, 2026, reporting the results of operations for the fiscal quarter ended January 31, 2026.
104
Cover Page Interactive Data File, formatted in Inline XBRL document.
1
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
By: /s/David Polinsky
Name: David Polinsky
Title: Chief Financial Officer
Dated: March 16, 2026
2
Exhibit Number
Document
99.1
Press Release, dated March 16, 2026, reporting the results of operations for the fiscal quarter ended January 31, 2026.
104
Cover Page Interactive Data File, formatted in Inline XBRL document.
3
Dec 11, 2025 · 100% conf.
1D
-0.20%
$1.49
Act: -2.01%
5D
-7.56%
$1.38
Act: -16.78%
20D
+0.05%
$1.49
false 0001713863
0001713863
2025-12-11 2025-12-11
0001713863
RFL:ClassBCommonStockParValue0.01PerShareMember
2025-12-11 2025-12-11
0001713863
RFL:WarrantToPurchaseClassBCommonStockMember
2025-12-11 2025-12-11
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 11, 2025
(Exact name of registrant as specified in its charter)
Delaware
1-38411
82-2296593
(State or other jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
520 Broad Street
Newark, New Jersey
07102
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: 212 658-1450
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b)-2 of the Exchange Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Class B common stock, par value $0.01 per share
RFL
New York Stock Exchange
Warrant to Purchase Class B common stock
NYSE American
Item 2.02. Results of Operations and Financial Condition.
On December 11, 2025, Rafael Holdings, Inc. (the “Company”) distributed over a wire service and posted an earnings release to the investors page of its website (www.rafaelholdings.com) announcing its results of operations for the fiscal quarter ended October 31, 2025. A copy of the earnings release concerning the foregoing results is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
The Company is furnishing the information contained in this Report, including Exhibit 99.1, pursuant to Item 2.02 of Form 8-K promulgated by the Securities and Exchange Commission (the “SEC”). This information shall not be deemed to be “filed” with the SEC or incorporated by reference into any other filing with the SEC unless otherwise expressly stated in such filing. In addition, this Report and the press release contain statements intended as “forward-looking statements” that are subject to the cautionary statements about forward-looking statements set forth in the press release.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Document
99.1
Press Release, dated December 11, 2025, reporting the results of operations for the fiscal quarter ended October 31, 2025.
104
Cover Page Interactive Data File, formatted in Inline XBRL document.
1
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
By: /s/ David Polinsky
Name: David Polinsky
Title: Chief Financial Officer
Dated: December 11, 2025
2
Exhibit Number
Document
99.1
Press Release, dated December 11, 2025, reporting the results of operations for the fiscal quarter ended October 31, 2025.
104
Cover Page Interactive Data File, formatted in Inline XBRL document.
3
Oct 29, 2025 · 100% conf.
1D
-0.20%
$1.49
Act: -2.01%
5D
-7.56%
$1.38
Act: -16.78%
20D
+0.05%
$1.49
false 0001713863
0001713863
2025-10-29 2025-10-29
0001713863
RFL:ClassBCommonStockParValue0.01PerShareMember
2025-10-29 2025-10-29
0001713863
RFL:WarrantToPurchaseClassBCommonStockMember
2025-10-29 2025-10-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 29, 2025
(Exact name of registrant as specified in its charter)
Delaware
1-38411
82-2296593
(State or other jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
520 Broad Street
Newark, New Jersey
07102
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: 212 658-1450
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b)-2 of the Exchange Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Class B common stock, par value $0.01 per share
RFL
New York Stock Exchange
Warrant to Purchase Class B common stock
NYSE American
Item 2.02. Results of Operations and Financial Condition.
On October 29, 2025, Rafael Holdings, Inc. (the “Company”) distributed over a wire service and posted an earnings release to the investors page of its website (www.rafaelholdings.com) announcing its results of operations for the fiscal quarter and fiscal year ended July 31, 2025. A copy of the earnings release concerning the foregoing results is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
The Company is furnishing the information contained in this Report, including Exhibit 99.1, pursuant to Item 2.02 of Form 8-K promulgated by the Securities and Exchange Commission (the “SEC”). This information shall not be deemed to be “filed” with the SEC or incorporated by reference into any other filing with the SEC unless otherwise expressly stated in such filing. In addition, this Report and the press release contain statements intended as “forward-looking statements” that are subject to the cautionary statements about forward-looking statements set forth in the press release.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Document
99.1
Press Release, dated October 29, 2025, reporting the results of operations for the fiscal quarter and fiscal year ended July 31, 2025.
104
Cover Page Interactive Data File, formatted in Inline XBRL document.
1
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
By: /s/ David Polinsky
Name: David Polinsky
Title: Chief Financial Officer
Dated: October 29, 2025
2
Exhibit
Number
Document
99.1
Press Release, dated October 29, 2025, reporting the results of operations for the fiscal quarter and fiscal year ended July 31, 2025.
104
Cover Page Interactive Data File, formatted in Inline XBRL document.
3
See how RFL stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "RFL Rafael Holdings Inc. Class B - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.